This protocol is judged by an institutional critique board, an independent group that opinions any scientific trials involving humans. If a research includes a Schedule I drug, once the board approves the protocol as moral, the scientists have to apply for an investigational new drug (IND) range within the FDA.When under the influence of the drug,